Antibacterial Polypeptide Libraries via Recombinant Bacterial Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying antimicrobial peptides are limited by the lack of high-throughput screening capabilities, preventing the broad testing of peptide chemistry and the identification of effective forms of antimicrobial peptides, especially for peptides longer than 15 amino acids, which are more stable and effective under physiological conditions.

Innovation Solution

A method involving the use of a recombinant bacterial cell system with a fusion protein comprising a secretion signal sequence, a candidate polypeptide sequence, an optional linker sequence, and a bacterial membrane anchor sequence, expressed under an inducible promoter, allowing for the identification of polypeptides with antibiotic activity by inducing expression and observing cell lysis, and subsequent sequencing to identify active sequences.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current antimicrobial peptide screening methods are used, then the process is simple, but the throughput is limited to small numbers of peptides

Engineering Contradiction:
Improvescreening throughputVSAvoidscreening system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the bacterial cell into functional compartments: the peptide library is divided into multiple clones, each expressing a different candidate peptide, while the screening process separates viable cells (peptide producers) from non-viable cells (consumers) based on their differential growth rates. This segmentation enables parallel evaluation of numerous peptides simultaneously.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces an intermediary mechanism using a parasitic bacterium that consumes amino acids from the environment. This intermediary creates a competitive interaction where the growth of one bacterial type (peptide producer) directly benefits another (amino acid consumer), providing an indirect but measurable indicator of peptide antimicrobial activity without requiring direct observation of peptide function.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If peptide libraries with diverse sequences are created, then the coverage of chemical space increases, but the difficulty of screening increases

Engineering Contradiction:
Improvepeptide sequence diversityVSAvoidscreening difficulty
Core Design Contradiction:
Adaptability or versatilityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent implements feedback through the parasitic bacterium's consumption of amino acids. The peptide-expressing bacteria provide amino acids to the environment, which directly feed the parasitic bacteria. This creates a self-reinforcing feedback loop where successful peptide producers (those with antimicrobial activity) automatically support the growth of the parasitic indicator, making diversity detection straightforward through monitoring of parasitic bacterial growth.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces complex mechanical or biochemical detection systems with a biological feedback mechanism. Instead of using sophisticated instruments to detect peptide activity, the system uses the natural metabolic interaction between bacteria to automatically reveal which peptides are active, simplifying the detection process while maintaining high throughput capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Productivity

If high-throughput screening is implemented, then the number of peptides tested increases, but the cost and complexity increase

Engineering Contradiction:
Improvenumber of peptides testedVSAvoidresource consumption
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent merges multiple functions into a single integrated system: the peptide library expression, the antimicrobial activity test, and the high-throughput screening are combined into one culture-based assay. The parasitic bacterium serves multiple purposes simultaneously as an indicator of peptide activity, a consumer of amino acids, and a competitor in the mixed culture, eliminating the need for separate detection steps and reducing overall resource consumption.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the rapid and efficient identification of polypeptides with antibiotic activity from large libraries, capable of lysing bacterial cells expressing them, thereby eliminating them from the population, and allows for the characterization of diverse candidate sequences, including those with varying physical characteristics.

Implementation Method 1

inducing expression of the fusion protein in the bacterial cells

Methodology Applied
Scientific EffectTranscriptional induction:

Implementation Method 2

Antimicrobial peptides are polypeptides, typically 15 to 50 amino acids in length that disrupt the bacterial outer membrane and cause cell lysis

Methodology Applied
Scientific EffectPore formation:

Data Source

PatentUS11136613B2Antibacterial polypeptide libraries and methods for screening the same
Publication Date: 2021.10.05 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US11136613B2 patent drawing
  • US11136613B2 patent drawing
  • US11136613B2 patent drawing

AI summary

Compositions and methods for isolating polypeptides having antibiotic activity are provided. In some aspects, bacterial cell populations are provided that express a surface-displayed library of candidate polypeptide sequences under the control of an inducible promoter.